Overview
Explore compounds researched for mitochondrial support, immune resilience, cellular aging pathways, and age-related performance decline.
11 of 46 published compounds
$371.52
Longevity & Anti-Aging
healthy aging, cellular resilience, mitochondrial support, long-term vitality
Goal hub next step
Build a longevity & healthy aging research path.
Use the quiz before choosing a compound, vendor, or PDF so the route reflects your goal, risk tolerance, and monitoring comfort.
Best options to research first
Ranked by evidence first, then risk. A research starting point, not a clinical recommendation.
Angiotensin 1-7
Protective renin-angiotensin-system peptide studied for vascular, anti-inflammatory, and anti-fibrotic effects.
intravenous, subcutaneous
Hemodynamic effects can appear quickly during infusion; structural outcomes are studied over longer periods.
0 tracked
Elamipretide
Clinical-stage mitochondria-targeting peptide binding cardiolipin. Not a typical consumer RUO product.
subcutaneous, intravenous
Trial endpoints measured over months in disease-specific contexts.
€371.52
1 tracked
Thymosin Alpha-1
Immunomodulatory peptide approved in various countries with broader clinical literature than most RUO peptides.
subcutaneous
Immune biomarkers and clinical outcomes over weeks to months.
$79.98
1 tracked
GHK-Cu
Copper peptide complex with substantial topical/cosmetic literature for skin and hair repair.
topical
Skin remodeling: weeks to months (collagen turnover cycles).
$60.00
3 tracked
Humanin
Mitochondrial-derived micropeptide with preclinical cytoprotective and neuroprotective research.
subcutaneous
Model-dependent in preclinical studies.
0 tracked
Lower-risk options
Angiotensin 1-7
Protective renin-angiotensin-system peptide studied for vascular, anti-inflammatory, and anti-fibrotic effects.
Elamipretide
Clinical-stage mitochondria-targeting peptide binding cardiolipin. Not a typical consumer RUO product.
Thymosin Alpha-1
Immunomodulatory peptide approved in various countries with broader clinical literature than most RUO peptides.
Pinealon
Obscure pineal peptide marketed for anti-aging and sleep support with very weak published evidence.
Trusted vendors for longevity-focused research
These vendors currently carry compounds in this goal category. Hub is the trust layer; outbound clicks happen after comparison.
XL Peptides
5 relevant compounds in hub
testing reports on product page
third-party testing reports linked on product page
UK, Europe, and rest of world via vendor shipping options
affiliate: direct product page
Amino Club
4 relevant compounds in hub
product page COA viewer
third-party purity testing; product-level COA on page
US/ROW (verify current policy)
affiliate: public program
Ignite Peptides
3 relevant compounds in hub
COA with order / verify current product report
third-party testing and COA documentation claimed by vendor; verify product-specific report
U.S. domestic territories only
affiliate: direct product page
Sources and review notes
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks - U.S. Food and Drug Administration - accessed 2026-05-15
Used for FDA compounding-risk context and peptide safety flags.
- The Prohibited List - World Anti-Doping Agency - accessed 2026-05-15
Used for athlete-facing WADA risk and peptide-class restrictions.
- Peptide therapeutics: current status and future directions - PubMed / Nature Reviews Drug Discovery - accessed 2026-05-15
Used for broad peptide-therapeutics background and evidence framing.